BioHealth News Archive
NIH and Lilly Collaborate, Aim to Make Drug Development Pipelines More Productive | Highlight HEALTH
Over the past decade, collaborative research efforts to support the discovery and development of medicines has increased dramatically. Last month, the National Institutes of…
Read MoreMedImmune central to AstraZeneca-Amgen antibody deal – Washington Business Journal
Pharmaceutical giants AstraZeneca PLC and Amgen Inc. just announced a deal to co-develop and co-commercialize five product candidates, all monoclonal antibodies. No surprise here: LLC …
Read MoreBiotech Can’t Sidestep Cost-Effectiveness Anymore | Xconomy
Back in the old days of biotech, the business was pretty straightforward. You’d craft your scientific idea, aim a new drug at patients in need,…
Read MoreWhat venture capitalists look for in personalized medicine investments
Companies like Starbucks (NASDAQ:SBUX), Amazon.com (NASDAQ:AMZN) and Apple (NASDAQ:AAPL) aren’t healthcare companies, but one venture capitalist believes their example can guide personalized medicine. Bob…
Read MoreGene mapping isn’t a crystal ball for future health… yet – NY Daily News
Gene scans for everyone? Not so fast. New research suggests that for the average person, decoding your own DNA may not turn out to…
Read MoreEmergent’s Fuad El-Hibri, an entrepreneur at heart
Fuad El-Hibri has started a financial consulting business. He’s started telecommunications businesses. But his most challenging venture has been the Rockville biotech he helped…
Read MoreUNH Center for Venture Research: U.S. Angel Investor Market on Solid Path of Recovery in 2011
Following a considerable contraction in investment dollars in 2008 and 2009, the U.S. angel investor market continued to recover in 2011, a trend that…
Read MoreAstraZeneca links up with Amgen for treatments development
Shares in AstraZeneca ticked up after the Anglo-Swedish drugs giant announced a tie-up with biotechnology giant Amgen to develop and commercialise five treatments. Under…
Read MoreBig Pharma Cozies Up to Biotech – DailyFinance
Pharmaceuticals have figured that out that if they can't be as innovative or nimble as biotechs, the next best option is to pay for…
Read MoreJohns Hopkins top R&D spender for 32nd straight year in 2010 – Baltimore Business Journal
Surprise, surprise — Johns Hopkins University spent more money on medical, science and engineering research than any other university in fiscal 2010. Hopkins…
Read MoreVideo Interview: America’s CTO Catalyzes Health Entrepreneurship through Open Data
No matter how privatized healthcare is in America, at the end of the day it remains a social sustainability issue and a government concern.…
Read MoreDingman Center for Entrepreneurship
Dingman Center Angels The Dingman Center Angels connects regional start-up companies seeking seed and early-stage funding with angel investors. Facts About Dingman Center Angels…
Read MoreSenator Barbara Mikulski: Mikulski Stands Up For Maryland’s Health Research And Innovation Economy
U.S. Senator Barbara A. Mikulski (D-Md.) U.S. Senator Barbara A. Mikulski (D-Md.), a senior member of the Senate Appropriations Committee, today spoke out in support…
Read MoreUMD Launches Entrepreneurship-Innovation Festival – Citybizlist Baltimore
On March 30, the University of Maryland launches its expanding lineup of competitions and activities devoted to innovation, ingenuity and ideas: 30 Days of…
Read MoreMaryland University, VC Partner on Start-Up Accelerator | Science Business
Loyola University in Baltimore, Maryland and Wasabi Ventures, a venture capital company in San Mateo, California, have begun a new-business accelerator near the university’s…
Read More